Device Trial Radar · NCT07800013
Full Core Biopsy Needle vs Side Notch Biopsy Needle
Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jul 1, 2025
Primary completion
Mar 1, 2026
Study completion Mar 1, 2026
Sponsor
- Lead sponsor
- West China HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Compare the quality of samples collected by the new fully automatic full-core biopsy needle with that of existing biopsy needles, including length, weight, and debris rate
Conditions
- Biopsy
Interventions
Merit Medical CorVocet full-core disposable biopsy needleDevice
Merit Medical CorVocet full-core disposable biopsy needle
Bard Side notch disposable biopsy needleDevice
Bard Side notch disposable biopsy needle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Length of specimenTime frame: From enrollment to the end of biopsy at 1 week
- MassTime frame: From enrollment to the end of biopsy at 1 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China hospital
Chengdu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.